PDS Biotechnology (PDSB) Shares Issued (2014 - 2026)
PDS Biotechnology's (PDSB) quarterly Shares Issued came in at $190799.0 in Q4 2025, down 96.45% YoY from $5.4 million in Q4 2024, and down 94.41% on a QoQ basis from $3.4 million in Q3 2025.
PDS Biotechnology (PDSB) Shares Issued (2014 - 2026) Analysis & Trends
PDS Biotechnology (PDSB) has 12 years of Shares Issued data on file, last reported at $190799.0 in Q4 2025.
- Quarterly Shares Issued fell 96.45% year-over-year to $190799.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $190799.0 (down 96.45% YoY) and the FY2025 annual result came in at $190799.0, down 96.45% from the prior year.
- Shares Issued fell to $190799.0 in Q4 2025, from $3.4 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $5.4 million in Q3 2023 to a low of $185315.0 in Q2 2023.
- A 5-year average of $2.6 million and a median of $2.5 million in 2024 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2024 — Shares Issued soared 1141.76% — and 2025, when it plunged 96.45%.
- Tracing PDSB's Shares Issued over 5 years: stood at $3.2 million in 2021, then soared by 31.84% to $4.2 million in 2022, then increased by 20.57% to $5.0 million in 2023, then climbed by 6.83% to $5.4 million in 2024, then sank by 96.45% to $190799.0 in 2025.
- The last three Shares Issued figures came in at $190799.0 (Q4 2025), $3.4 million (Q3 2025), and $957407.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.41 Mn |
| Jun 30, 2026 | 9.41 Mn |
| Dec 31, 2025 | 190,799.00 |
| Dec 31, 2025 | 190,799.00 |
| Sep 30, 2025 | 3.41 Mn |
| Sep 30, 2025 | 3.41 Mn |
| Jun 30, 2025 | 957,407.00 |
| Jun 30, 2025 | 957,407.00 |
| Mar 31, 2025 | 5.35 Mn |
| Mar 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 5.37 Mn |
| Dec 31, 2024 | 5.37 Mn |
| Sep 30, 2024 | 969,407.00 |
| Sep 30, 2024 | 969,407.00 |
| Jun 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | 5.03 Mn |
| Dec 31, 2023 | 5.03 Mn |